Medicare Enrolled

Dr. Michael Rezak, MD, PHD

Neurology · Park Ridge, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1875 DEMPSTER ST STE 625, Park Ridge, IL 60068
8477234088
In practice since 2006 (19 years)
NPI: 1003975897 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rezak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rezak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rezak

Dr. Michael Rezak is a neurology specialist in Park Ridge, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rezak performed 15,128 Medicare services across 431 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rezak received a total of $259,057 from 21 pharmaceutical and/or device companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rezak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 4% volume in IL $259,057 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,128
Medicare services
Top 4% in IL for neurology
431
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~796 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
14,385 $5 $9
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
423 $92 $231
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
77 $131 $314
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 51 $64 $199
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $67 $157
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $47 $94
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
33 $136 $356
New patient office visit, complex (60-74 min) 33 $167 $449
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
26 $15 $184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$259,057
Total received (2018-2024)
Avg $37,008/year across 7 years
Top 3% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220,556 (85.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$36,815 (14.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,686 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$468
2023
$15,356
2022
$37,866
2021
$53,383
2020
$30,333
2019
$45,940
2018
$75,712

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$216
Neurocrine Biosciences, Inc.
$81
Teva Pharmaceuticals USA, Inc.
$50
ACADIA Pharmaceuticals Inc
$41
Medtronic, Inc.
$38
Amneal Pharmaceuticals LLC
$23
Kyowa Kirin, Inc.
$19
Top 3 companies account for 74.1% of 2024 payments
All-time payments by company (2018-2024) ›
Kyowa Kirin, Inc.
$47,219
AbbVie, Inc.
$46,207
Lundbeck LLC
$33,992
Amneal Pharmaceuticals LLC
$20,241
Teva Pharmaceuticals USA, Inc.
$20,158
ACADIA Pharmaceuticals Inc
$17,798
MDD US Operations, LLC
$15,726
AbbVie Inc.
$14,551
UCB, Inc.
$9,323
US WorldMeds, LLC
$8,649
ABBVIE INC.
$6,543
Adamas Pharmaceuticals, Inc.
$6,400
GE Healthcare
$3,423
Boston Scientific Corporation
$3,293
Medtronic, Inc.
$3,269
Acorda Therapeutics, Inc
$1,365
Medtronic USA, Inc.
$419
Neurocrine Biosciences, Inc.
$229
Alexion Pharmaceuticals, Inc.
$125
Abbott Laboratories
$111
Allergan, Inc.
$17
Top 3 companies account for 49.2% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AJOVY · APOKYN · AUSTEDO · Austedo XR · BOTOX · DATSCAN · DUOPA · Duopa · GENERAL DBS · GENERAL THERAPIES · GENERAL DBS · GOCOVRI · General - DBS · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · MYOBLOC · NORTHERA · NOURIANZ · NUPLAZID · Neupro · Nourianz · Ongentys · PERCEPT PC BRAINSENSE · RYTARY · Soliris · VERCISE · VYALEV · Xadago
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in IL.

Looking for a neurology specialist in Park Ridge?
Compare neurologists in the Park Ridge area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
621
Per 100K population
12.0
County median income
$81,797
Nearest hospital
ADVOCATE LUTHERAN GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rezak is a mixed practice specialist, with above-average Medicare volume (top 4% in IL), with speaking/promotional industry engagement in the top 3% of IL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rezak experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rezak performed 14,385 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rezak receive payments from pharmaceutical companies?
Yes. Dr. Rezak received a total of $259,057 from 21 companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rezak's costs compare to other neurologists in Park Ridge?
Dr. Rezak's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rezak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →